PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaCommercial · Coverage · Surgery · Cardiology, Cardiothoracic SurgeryMedium impact

Transcatheter Aortic Valve Implantation (CPB 0826, reviewed 2026-10-28)

Effective date
Not stated in the notice
Identified
Oct 29, 2026

Summary

Aetna considers transcatheter aortic valve implantation (TAVI) medically necessary when criteria are met. Those criteria cover severe symptomatic calcified native aortic valve stenosis without severe aortic insufficiency and an ejection fraction greater than 20%, and valve-in-valve replacement of a degenerated bioprosthetic aortic valve in patients with a Society of Thoracic Surgeons operative risk score of 8% or greater or a judged 15% or greater risk of mortality from surgical replacement. Percutaneous repair of prosthetic paravalvular leak is also considered medically necessary under specific conditions, while BASILICA, combined TAVI and left atrial appendage occlusion, embolic protection devices, TAVI for ongoing sepsis or endocarditis, and several prognostic tests are listed as experimental, investigational or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Billing team: Bill TAVI codes 33361 through 33369 only for members who meet the selection criteria in this policy, using an FDA-approved valve such as the Edwards Sapien 3, Edwards Sapien XT, Edwards Sapien transcatheter heart valve, or Medtronic CoreValve System.
02For native valve stenosis, the criteria are severe symptomatic calcified native aortic valve stenosis without severe aortic insufficiency, an ejection fraction greater than 20%, and co-morbidities that would not preclude the expected benefit from correcting the stenosis.
03For valve-in-valve replacement of a degenerated bioprosthetic aortic valve, the criteria are a Society of Thoracic Surgeons operative risk score of 8% or greater, or a judged 15% or greater risk of mortality for surgical aortic valve replacement.
04For transcatheter closure of paravalvular leak (CPT 93590 - 93592), the policy considers the procedure medically necessary when all of these conditions are met: the member has intractable hemolysis or NYHA class III or IV symptoms, the member is at high or prohibitive risk for surgery, the member has anatomic features suitable for catheter-based therapy, and the procedure is performed at a comprehensive valve center.
05Do not bill BASILICA, combined TAVI and left atrial appendage occlusion, TAVI with pre-implantation balloon aortic valvuloplasty, or use of embolic protection devices during TAVI, because the policy lists these as experimental, investigational or unproven.

Codes mentioned

33361333623336333364333653336633367333683336933370929869359093592I06.0I08.0I35.0I35.9Q23.0T82.01XAT82.01XST82.03XAT82.03XST82.857AT82.857SZ45.09I06.1I33.0I33.9I70.0N17.0N17.9N99.0Q23.1A40.0A40.9A41.01A41.9T80.211AT80.29XST81.40XAT81.49XST88.0XXAT88.0XXS

Original notice

Transcatheter Aortic Valve Implantation (CPB 0826, reviewed 2026-10-28)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account